Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

PHASE2CompletedINTERVENTIONAL

Enrollment

167

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions

End Stage Renal DiseaseChronic Kidney DiseaseHyperphosphatemicKidney Disease

Interventions

DRUG

AMG 223

1.0 g TID orally 3.0 g TID orally 4.0 g TID orally 5.0 g TID orally

DRUG

Placebo

1.0 g TID orally 3.0 g TID orally 4.0 g TID orally 5.0 g TID orally